Comparison of Electronic Surveillance With Routine Monitoring for Patients With Lymphoma at High Risk of Relapse: Prospective Randomized Controlled Phase 3 Trial (Sentinel Lymphoma)

The primary objective was not reached; however, patient-reported outcome measures remain essential for detecting adverse events in patients with cancer, and the electronic monitoring method needs to demonstrate its effectiveness and comply with international safety guidelines.

Authors

Institutions

Publication Details

Journal
JMIR Cancer
Published
2025-03-31
DOI
https://doi.org/10.2196/65960
Citations
1
Primary Topic
Cancer survivorship and care
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison of Electronic Surveillance With Routine Monitoring for Patients With Lymphoma at High Risk of Relapse: Prospective Randomized Controlled Phase 3 Trial (Sentinel Lymphoma)

A. Saint‐Lézer, Adrien Chauchet, Anne Parcelier, Anne‐Lise Adenot‐Engelvin et al.
1 citations
JMIR Cancer
Cancer survivorship and care
1.05
article

Comparison of Electronic Surveillance With Routine Monitoring for Patients With Lymphoma at High Risk of Relapse: Prospective Randomized Controlled Phase 3 Trial (Sentinel Lymphoma)

A. Saint‐Lézer, Adrien Chauchet, Anne Parcelier, Anne‐Lise Adenot‐Engelvin, Sophie Sadot‐Lebouvier, Katell Le Dû, Magali Balavoine, Frédéric Maloisel, Fontanet Bijou, Sylvain Carras, Cédric Rossi, Olivier Fitoussi
article en
1 citations

Abstract

The primary objective was not reached; however, patient-reported outcome measures remain essential for detecting adverse events in patients with cancer, and the electronic monitoring method needs to demonstrate its effectiveness and comply with international safety guidelines.

JMIR CancerVol. 11
Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR), Centre Hospitalier Universitaire de Grenoble (FR), Centre Hospitalier Universitaire de Besançon (FR), Methodology and Quality of Life Unit in Oncology (FR), Centre hospitalier Bretagne Atlantique (FR), CEA Le Ripault (FR), Polyclinique Bordeaux Nord Aquitaine (FR), CHU Dijon Bourgogne (FR), Regional Cancer Center (US), Montagu Hospital (GB), Centre Hospitalier Sainte-Anne (FR), Epigénétique et Destin Cellulaire (FR), Institut Bergonié (FR), Hôpital privé du Confluent (FR), Maison des Sciences sociales et des Humanités de Dijon (FR), Clinique Ambroise Paré (FR), Université Grenoble Alpes (FR)
Openalex Percentile: Top 24%
Cancer survivorship and care
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.